The global Molecular Diagnostics for Infectious Diseases market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The USA market for Global Molecular Diagnostics for Infectious Diseases market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Molecular Diagnostics for Infectious Diseases market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Molecular Diagnostics for Infectious Diseases market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Molecular Diagnostics for Infectious Diseases market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Molecular Diagnostics for Infectious Diseases market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Molecular Diagnostics for Infectious Diseases, challenges faced by the industry, and potential opportunities for market players.
The global Molecular Diagnostics for Infectious Diseases market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Molecular Diagnostics for Infectious Diseases market presents opportunities for various stakeholders, including Hospital, Diagnostic Laboratories. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Molecular Diagnostics for Infectious Diseases market. Additionally, the growing consumer demand present avenues for market expansion.
The market for molecular diagnostics in infectious diseases is characterized by rapid technological advancements and a growing emphasis on accurate and timely disease detection. Molecular diagnostics involve the identification of pathogens at the molecular level, enabling quicker and more precise diagnosis of infectious diseases. Factors such as the increasing incidence of infectious diseases, demand for point-of-care testing, and advancements in genomics contribute to the market's expansion. Key players in the industry focus on developing innovative diagnostic platforms and expanding their product portfolios to meet the rising demand for molecular diagnostic solutions. The market is anticipated to experience continuous growth as molecular diagnostics become integral in managing infectious diseases globally, offering benefits such as early detection, personalized treatment strategies, and monitoring of treatment effectiveness.
Key Features:
The research report on the Molecular Diagnostics for Infectious Diseases market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Molecular Diagnostics for Infectious Diseases market.
Market Overview: The report provides a comprehensive overview of the Molecular Diagnostics for Infectious Diseases market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Respiratory Tract Infections, Reproductive Tract Infections), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Molecular Diagnostics for Infectious Diseases market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Molecular Diagnostics for Infectious Diseases market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Molecular Diagnostics for Infectious Diseases market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Molecular Diagnostics for Infectious Diseases market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Molecular Diagnostics for Infectious Diseases market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Molecular Diagnostics for Infectious Diseases market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Molecular Diagnostics for Infectious Diseases, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Molecular Diagnostics for Infectious Diseases market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Molecular Diagnostics for Infectious Diseases market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Respiratory Tract Infections
- Reproductive Tract Infections
- Blood-borne Infections (BBIs)
- Gastrointestinal Infections (GIIs)
- Other Infections
Market segment by Application
- Hospital
- Diagnostic Laboratories
Global Molecular Diagnostics for Infectious Diseases Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Roche Diagnostics
- Illumina
- Qiagen
- Abbott Laboratories
- BioMrieux
- Cepheid (Danaher)
- Thermo Fisher Scientific
- Hologic
- DiaSorin
- Luminex
- Hoffmann-La Roche
- Biocartis
- Nanomix
- BioFire Diagnostics
- Seegene
- QuidelOrtho
- ZeptoMetrix
- Sansure
- BGI Genomics
- DaAn Gene
- Kehua Bio-engineering
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnostics for Infectious Diseases, market overview.
Chapter 2: Global Molecular Diagnostics for Infectious Diseases market size in revenue and volume.
Chapter 3: Detailed analysis of Molecular Diagnostics for Infectious Diseases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnostics for Infectious Diseases in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Molecular Diagnostics for Infectious Diseases capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics for Infectious Diseases Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics for Infectious Diseases Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics for Infectious Diseases Overall Market Size
2.1 Global Molecular Diagnostics for Infectious Diseases Market Size: 2023 VS 2030
2.2 Global Molecular Diagnostics for Infectious Diseases Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Molecular Diagnostics for Infectious Diseases Sales: 2019-2030
3 Company Landscape
3.1 Top Molecular Diagnostics for Infectious Diseases Players in Global Market
3.2 Top Global Molecular Diagnostics for Infectious Diseases Companies Ranked by Revenue
3.3 Global Molecular Diagnostics for Infectious Diseases Revenue by Companies
3.4 Global Molecular Diagnostics for Infectious Diseases Sales by Companies
3.5 Global Molecular Diagnostics for Infectious Diseases Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Molecular Diagnostics for Infectious Diseases Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Molecular Diagnostics for Infectious Diseases Product Type
3.8 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics for Infectious Diseases Players in Global Market
3.8.1 List of Global Tier 1 Molecular Diagnostics for Infectious Diseases Companies
3.8.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics for Infectious Diseases Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnostics for Infectious Diseases Market Size Markets, 2023 & 2030
4.1.2 Respiratory Tract Infections
4.1.3 Reproductive Tract Infections
4.1.4 Blood-borne Infections (BBIs)
4.1.5 Gastrointestinal Infections (GIIs)
4.1.6 Other Infections
4.2 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue, 2019-2024
4.2.2 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue, 2025-2030
4.2.3 By Type - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
4.3 By Type - Global Molecular Diagnostics for Infectious Diseases Sales & Forecasts
4.3.1 By Type - Global Molecular Diagnostics for Infectious Diseases Sales, 2019-2024
4.3.2 By Type - Global Molecular Diagnostics for Infectious Diseases Sales, 2025-2030
4.3.3 By Type - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
4.4 By Type - Global Molecular Diagnostics for Infectious Diseases Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics for Infectious Diseases Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Diagnostic Laboratories
5.2 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue, 2019-2024
5.2.2 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue, 2025-2030
5.2.3 By Application - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
5.3 By Application - Global Molecular Diagnostics for Infectious Diseases Sales & Forecasts
5.3.1 By Application - Global Molecular Diagnostics for Infectious Diseases Sales, 2019-2024
5.3.2 By Application - Global Molecular Diagnostics for Infectious Diseases Sales, 2025-2030
5.3.3 By Application - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
5.4 By Application - Global Molecular Diagnostics for Infectious Diseases Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics for Infectious Diseases Market Size, 2023 & 2030
6.2 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue, 2019-2024
6.2.2 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue, 2025-2030
6.2.3 By Region - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
6.3 By Region - Global Molecular Diagnostics for Infectious Diseases Sales & Forecasts
6.3.1 By Region - Global Molecular Diagnostics for Infectious Diseases Sales, 2019-2024
6.3.2 By Region - Global Molecular Diagnostics for Infectious Diseases Sales, 2025-2030
6.3.3 By Region - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.4.2 By Country - North America Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.4.3 US Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.4.4 Canada Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.4.5 Mexico Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.5.2 By Country - Europe Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.5.3 Germany Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.4 France Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.5 U.K. Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.6 Italy Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.7 Russia Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.8 Nordic Countries Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.5.9 Benelux Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.6.2 By Region - Asia Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.6.3 China Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.4 Japan Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.5 South Korea Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.6 Southeast Asia Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.6.7 India Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.7.2 By Country - South America Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.7.3 Brazil Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.7.4 Argentina Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales, 2019-2030
6.8.3 Turkey Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8.4 Israel Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8.5 Saudi Arabia Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
6.8.6 UAE Molecular Diagnostics for Infectious Diseases Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Company Summary
7.1.2 Roche Diagnostics Business Overview
7.1.3 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.1.4 Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.1.5 Roche Diagnostics Key News & Latest Developments
7.2 Illumina
7.2.1 Illumina Company Summary
7.2.2 Illumina Business Overview
7.2.3 Illumina Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.2.4 Illumina Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.2.5 Illumina Key News & Latest Developments
7.3 Qiagen
7.3.1 Qiagen Company Summary
7.3.2 Qiagen Business Overview
7.3.3 Qiagen Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.3.4 Qiagen Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.3.5 Qiagen Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.4.4 Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 BioM?rieux
7.5.1 BioM?rieux Company Summary
7.5.2 BioM?rieux Business Overview
7.5.3 BioM?rieux Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.5.4 BioM?rieux Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.5.5 BioM?rieux Key News & Latest Developments
7.6 Cepheid (Danaher)
7.6.1 Cepheid (Danaher) Company Summary
7.6.2 Cepheid (Danaher) Business Overview
7.6.3 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.6.4 Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.6.5 Cepheid (Danaher) Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.7.4 Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Hologic
7.8.1 Hologic Company Summary
7.8.2 Hologic Business Overview
7.8.3 Hologic Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.8.4 Hologic Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.8.5 Hologic Key News & Latest Developments
7.9 DiaSorin
7.9.1 DiaSorin Company Summary
7.9.2 DiaSorin Business Overview
7.9.3 DiaSorin Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.9.4 DiaSorin Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.9.5 DiaSorin Key News & Latest Developments
7.10 Luminex
7.10.1 Luminex Company Summary
7.10.2 Luminex Business Overview
7.10.3 Luminex Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.10.4 Luminex Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.10.5 Luminex Key News & Latest Developments
7.11 Hoffmann-La Roche
7.11.1 Hoffmann-La Roche Company Summary
7.11.2 Hoffmann-La Roche Business Overview
7.11.3 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.11.4 Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.11.5 Hoffmann-La Roche Key News & Latest Developments
7.12 Biocartis
7.12.1 Biocartis Company Summary
7.12.2 Biocartis Business Overview
7.12.3 Biocartis Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.12.4 Biocartis Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.12.5 Biocartis Key News & Latest Developments
7.13 Nanomix
7.13.1 Nanomix Company Summary
7.13.2 Nanomix Business Overview
7.13.3 Nanomix Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.13.4 Nanomix Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.13.5 Nanomix Key News & Latest Developments
7.14 BioFire Diagnostics
7.14.1 BioFire Diagnostics Company Summary
7.14.2 BioFire Diagnostics Business Overview
7.14.3 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.14.4 BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.14.5 BioFire Diagnostics Key News & Latest Developments
7.15 Seegene
7.15.1 Seegene Company Summary
7.15.2 Seegene Business Overview
7.15.3 Seegene Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.15.4 Seegene Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.15.5 Seegene Key News & Latest Developments
7.16 QuidelOrtho
7.16.1 QuidelOrtho Company Summary
7.16.2 QuidelOrtho Business Overview
7.16.3 QuidelOrtho Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.16.4 QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.16.5 QuidelOrtho Key News & Latest Developments
7.17 ZeptoMetrix
7.17.1 ZeptoMetrix Company Summary
7.17.2 ZeptoMetrix Business Overview
7.17.3 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.17.4 ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.17.5 ZeptoMetrix Key News & Latest Developments
7.18 Sansure
7.18.1 Sansure Company Summary
7.18.2 Sansure Business Overview
7.18.3 Sansure Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.18.4 Sansure Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.18.5 Sansure Key News & Latest Developments
7.19 BGI Genomics
7.19.1 BGI Genomics Company Summary
7.19.2 BGI Genomics Business Overview
7.19.3 BGI Genomics Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.19.4 BGI Genomics Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.19.5 BGI Genomics Key News & Latest Developments
7.20 DaAn Gene
7.20.1 DaAn Gene Company Summary
7.20.2 DaAn Gene Business Overview
7.20.3 DaAn Gene Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.20.4 DaAn Gene Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.20.5 DaAn Gene Key News & Latest Developments
7.21 Kehua Bio-engineering
7.21.1 Kehua Bio-engineering Company Summary
7.21.2 Kehua Bio-engineering Business Overview
7.21.3 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Major Product Offerings
7.21.4 Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales and Revenue in Global (2019-2024)
7.21.5 Kehua Bio-engineering Key News & Latest Developments
8 Global Molecular Diagnostics for Infectious Diseases Production Capacity, Analysis
8.1 Global Molecular Diagnostics for Infectious Diseases Production Capacity, 2019-2030
8.2 Molecular Diagnostics for Infectious Diseases Production Capacity of Key Manufacturers in Global Market
8.3 Global Molecular Diagnostics for Infectious Diseases Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Molecular Diagnostics for Infectious Diseases Supply Chain Analysis
10.1 Molecular Diagnostics for Infectious Diseases Industry Value Chain
10.2 Molecular Diagnostics for Infectious Diseases Upstream Market
10.3 Molecular Diagnostics for Infectious Diseases Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Molecular Diagnostics for Infectious Diseases Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Molecular Diagnostics for Infectious Diseases in Global Market
Table 2. Top Molecular Diagnostics for Infectious Diseases Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Molecular Diagnostics for Infectious Diseases Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Molecular Diagnostics for Infectious Diseases Revenue Share by Companies, 2019-2024
Table 5. Global Molecular Diagnostics for Infectious Diseases Sales by Companies, (K Units), 2019-2024
Table 6. Global Molecular Diagnostics for Infectious Diseases Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Molecular Diagnostics for Infectious Diseases Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Molecular Diagnostics for Infectious Diseases Product Type
Table 9. List of Global Tier 1 Molecular Diagnostics for Infectious Diseases Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Molecular Diagnostics for Infectious Diseases Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Molecular Diagnostics for Infectious Diseases Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Molecular Diagnostics for Infectious Diseases Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Molecular Diagnostics for Infectious Diseases Sales (K Units), 2019-2024
Table 15. By Type - Global Molecular Diagnostics for Infectious Diseases Sales (K Units), 2025-2030
Table 16. By Application ? Global Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Molecular Diagnostics for Infectious Diseases Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Molecular Diagnostics for Infectious Diseases Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Molecular Diagnostics for Infectious Diseases Sales (K Units), 2019-2024
Table 20. By Application - Global Molecular Diagnostics for Infectious Diseases Sales (K Units), 2025-2030
Table 21. By Region ? Global Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Molecular Diagnostics for Infectious Diseases Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Molecular Diagnostics for Infectious Diseases Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Molecular Diagnostics for Infectious Diseases Sales (K Units), 2019-2024
Table 25. By Region - Global Molecular Diagnostics for Infectious Diseases Sales (K Units), 2025-2030
Table 26. By Country - North America Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2019-2024
Table 29. By Country - North America Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2025-2030
Table 30. By Country - Europe Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2019-2024
Table 33. By Country - Europe Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2025-2030
Table 34. By Region - Asia Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2019-2024
Table 37. By Region - Asia Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2025-2030
Table 38. By Country - South America Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2019-2024
Table 41. By Country - South America Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales, (K Units), 2025-2030
Table 46. Roche Diagnostics Company Summary
Table 47. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Product Offerings
Table 48. Roche Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Roche Diagnostics Key News & Latest Developments
Table 50. Illumina Company Summary
Table 51. Illumina Molecular Diagnostics for Infectious Diseases Product Offerings
Table 52. Illumina Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Illumina Key News & Latest Developments
Table 54. Qiagen Company Summary
Table 55. Qiagen Molecular Diagnostics for Infectious Diseases Product Offerings
Table 56. Qiagen Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Qiagen Key News & Latest Developments
Table 58. Abbott Laboratories Company Summary
Table 59. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Product Offerings
Table 60. Abbott Laboratories Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Abbott Laboratories Key News & Latest Developments
Table 62. BioM?rieux Company Summary
Table 63. BioM?rieux Molecular Diagnostics for Infectious Diseases Product Offerings
Table 64. BioM?rieux Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. BioM?rieux Key News & Latest Developments
Table 66. Cepheid (Danaher) Company Summary
Table 67. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Product Offerings
Table 68. Cepheid (Danaher) Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Cepheid (Danaher) Key News & Latest Developments
Table 70. Thermo Fisher Scientific Company Summary
Table 71. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Product Offerings
Table 72. Thermo Fisher Scientific Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Thermo Fisher Scientific Key News & Latest Developments
Table 74. Hologic Company Summary
Table 75. Hologic Molecular Diagnostics for Infectious Diseases Product Offerings
Table 76. Hologic Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Hologic Key News & Latest Developments
Table 78. DiaSorin Company Summary
Table 79. DiaSorin Molecular Diagnostics for Infectious Diseases Product Offerings
Table 80. DiaSorin Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. DiaSorin Key News & Latest Developments
Table 82. Luminex Company Summary
Table 83. Luminex Molecular Diagnostics for Infectious Diseases Product Offerings
Table 84. Luminex Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Luminex Key News & Latest Developments
Table 86. Hoffmann-La Roche Company Summary
Table 87. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Product Offerings
Table 88. Hoffmann-La Roche Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Hoffmann-La Roche Key News & Latest Developments
Table 90. Biocartis Company Summary
Table 91. Biocartis Molecular Diagnostics for Infectious Diseases Product Offerings
Table 92. Biocartis Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Biocartis Key News & Latest Developments
Table 94. Nanomix Company Summary
Table 95. Nanomix Molecular Diagnostics for Infectious Diseases Product Offerings
Table 96. Nanomix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Nanomix Key News & Latest Developments
Table 98. BioFire Diagnostics Company Summary
Table 99. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Product Offerings
Table 100. BioFire Diagnostics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. BioFire Diagnostics Key News & Latest Developments
Table 102. Seegene Company Summary
Table 103. Seegene Molecular Diagnostics for Infectious Diseases Product Offerings
Table 104. Seegene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Seegene Key News & Latest Developments
Table 106. QuidelOrtho Company Summary
Table 107. QuidelOrtho Molecular Diagnostics for Infectious Diseases Product Offerings
Table 108. QuidelOrtho Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. QuidelOrtho Key News & Latest Developments
Table 110. ZeptoMetrix Company Summary
Table 111. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Product Offerings
Table 112. ZeptoMetrix Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. ZeptoMetrix Key News & Latest Developments
Table 114. Sansure Company Summary
Table 115. Sansure Molecular Diagnostics for Infectious Diseases Product Offerings
Table 116. Sansure Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 117. Sansure Key News & Latest Developments
Table 118. BGI Genomics Company Summary
Table 119. BGI Genomics Molecular Diagnostics for Infectious Diseases Product Offerings
Table 120. BGI Genomics Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 121. BGI Genomics Key News & Latest Developments
Table 122. DaAn Gene Company Summary
Table 123. DaAn Gene Molecular Diagnostics for Infectious Diseases Product Offerings
Table 124. DaAn Gene Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 125. DaAn Gene Key News & Latest Developments
Table 126. Kehua Bio-engineering Company Summary
Table 127. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Product Offerings
Table 128. Kehua Bio-engineering Molecular Diagnostics for Infectious Diseases Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 129. Kehua Bio-engineering Key News & Latest Developments
Table 130. Molecular Diagnostics for Infectious Diseases Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 131. Global Molecular Diagnostics for Infectious Diseases Capacity Market Share of Key Manufacturers, 2022-2024
Table 132. Global Molecular Diagnostics for Infectious Diseases Production by Region, 2019-2024 (K Units)
Table 133. Global Molecular Diagnostics for Infectious Diseases Production by Region, 2025-2030 (K Units)
Table 134. Molecular Diagnostics for Infectious Diseases Market Opportunities & Trends in Global Market
Table 135. Molecular Diagnostics for Infectious Diseases Market Drivers in Global Market
Table 136. Molecular Diagnostics for Infectious Diseases Market Restraints in Global Market
Table 137. Molecular Diagnostics for Infectious Diseases Raw Materials
Table 138. Molecular Diagnostics for Infectious Diseases Raw Materials Suppliers in Global Market
Table 139. Typical Molecular Diagnostics for Infectious Diseases Downstream
Table 140. Molecular Diagnostics for Infectious Diseases Downstream Clients in Global Market
Table 141. Molecular Diagnostics for Infectious Diseases Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Molecular Diagnostics for Infectious Diseases Segment by Type in 2023
Figure 2. Molecular Diagnostics for Infectious Diseases Segment by Application in 2023
Figure 3. Global Molecular Diagnostics for Infectious Diseases Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Molecular Diagnostics for Infectious Diseases Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Molecular Diagnostics for Infectious Diseases Revenue, 2019-2030 (US$, Mn)
Figure 7. Molecular Diagnostics for Infectious Diseases Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Molecular Diagnostics for Infectious Diseases Revenue in 2023
Figure 9. By Type - Global Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 11. By Type - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 12. By Type - Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 15. By Application - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 16. By Application - Global Molecular Diagnostics for Infectious Diseases Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 20. By Region - Global Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 21. By Country - North America Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 22. By Country - North America Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 23. US Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 28. Germany Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 29. France Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 37. China Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 41. India Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 43. By Country - South America Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 44. Brazil Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Molecular Diagnostics for Infectious Diseases Sales Market Share, 2019-2030
Figure 48. Turkey Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Molecular Diagnostics for Infectious Diseases Revenue, (US$, Mn), 2019-2030
Figure 52. Global Molecular Diagnostics for Infectious Diseases Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Molecular Diagnostics for Infectious Diseases by Region, 2023 VS 2030
Figure 54. Molecular Diagnostics for Infectious Diseases Industry Value Chain
Figure 55. Marketing Channels
